Bright Minds Biosciences Inc. (DRUG) Revenue History
Annual and quarterly revenue from 2019 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
DRUG Revenue Growth
DRUG Revenue Analysis (2019–2025)
As of May 8, 2026, Bright Minds Biosciences Inc. (DRUG) generated trailing twelve-month (TTM) revenue of $0. The most recent quarter (Q4 2025) recorded $0 in revenue.
Looking at the longer-term picture, DRUG's historical revenue data shows various trends over time.
When compared to Healthcare sector peers including ATAI (+811.8% YoY), and NRXP. Compare DRUG vs ATAI →
DRUG Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| DRUGCurrent | $0 | - | - | - | |
 ATAI | $308,000 | +811.8% | - | -33341.2% | |
 NRXP | $1M | - | - | -1324.4% |
DRUG Historical Revenue Data (2019–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $0 | - | $-55,191 | - | $-13,937,584 | - |
| 2024 | $0 | - | $0 | - | $-2,616,636 | - |
| 2023 | $0 | - | $0 | - | $-7,199,763 | - |
| 2022 | $0 | - | $0 | - | $-14,732,012 | - |
| 2021 | $0 | - | $0 | - | $-8,623,119 | - |
| 2020 | $0 | - | $0 | - | $-474,926 | - |
| 2019 | $0 | - | $0 | - | $-236,151 | - |
See DRUG's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs DRUG Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare DRUG vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonDRUG — Frequently Asked Questions
Quick answers to the most common questions about buying DRUG stock.
Is DRUG's revenue growth accelerating or slowing?
DRUG TTM revenue: $0.00. YoY growth: N/A. 5-year CAGR: N/A.
What is DRUG's long-term revenue growth rate?
Bright Minds Biosciences Inc.'s 5-year revenue CAGR of N/A reflects the variable expansion pattern. Current YoY growth of N/A is near this long-term average.
How is DRUG's revenue distributed by segment?
DRUG reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2019-2025 are available for download. Segment mix reveals concentration and diversification trends.